Abstract
Rab-like 3 (RABL3) is a member of Rab family that is related with several kinds of cancers. However, the functional roles of RABL3 in oral squamous cell carcinoma (OSCC) remain largely unknown. In the current study, we examined the expression levels of RABL3 in OSCC tissues and cell lines. The results showed that RABL3 expression was markedly increased in OSCC tissues and cell lines. Knockdown of RABL3 significantly suppressed the proliferation, migration and invasion of OSCC cells. Overexpression of RABL3 exhibited opposite effects with RABL3 knockdown. In vivo assay demonstrated that knockdown of RABL3 suppressed the tumorigenesis of OSCC. Moreover, RABL3 regulated the activation of focal adhesion kinase (FAK)/protein kinase B (Akt) signaling pathway in OSCC cells. Inhibition of FAK reversed the effects of RABL3 overexpression on cell proliferation, migration and invasion of OSCC cells. In conclusion, these findings demonstrated that RABL3 acted as an oncogene in OSCC, which was attributed to the regulation of FAK/Akt pathway. Thus, RABL3 may be potential therapeutic target for the treatment of OSCC.
Similar content being viewed by others
References
An J, Liu Z, Liang Q, Pan Y, Li H, Wang R, Jin Y (2017) Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Hum Pathol 67(1):146–151
da Silva SD, Marchi FA, Xu B, Bijian K, Alobaid F, Mlynarek A, Rogatto SR, Hier M, Kowalski LP, Alaoui-Jamali MA (2015) Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget 6(26):21950–21963
Dumache R (2017) Early diagnosis of oral squamous cell carcinoma by salivary microRNAs. Clin Lab 63(11):1771–1776
Fanaras N, Warnakulasuriya S (2016) Oral cancer diagnosis in primary care. Prim Dent J 5(1):64–68
Gilmore AP, Romer LH (1996) Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7(8):1209–1224
Guadagno NA, Progida C (2019) Rab GTPases: switching to human diseases. Cells 8(8):909–933
Li G, Marlin MC (2015) Rab family of GTPases. Methods Mol Biol 1298(1):1–15
Li Q, Wang L, Zeng L, Zhang Y, Li K, Jin P, Su B, Wang L (2010) Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells. Oncol Rep 24(2):433–440
Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, Lv EF, Zou G, Wang C, Si C, Zou L, Li C, Gao QX (2018) CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 37(1):46
Lv PC, Jiang AQ, Zhang WM, Zhu HL (2018) FAK inhibitors in cancer, a patent review. Expert Opin Ther Pat 28(2):139–145
Nguyen K, Yan Y, Yuan B, Dasgupta A, Sun J, Mu H, Do KA, Ueno NT, Andreeff M, Battula VL (2018) ST8SIA1 regulates tumor growth and metastasis in TNBC by activating the FAK-AKT-mTOR signaling pathway. Mol Cancer Ther 17(12):2689–2701
Nissim S, Leshchiner I, Mancias JD, Greenblatt MB, Maertens O, Cassa CA, Rosenfeld JA, Cox AG, Hedgepeth J, Wucherpfennig JI, Kim AJ, Henderson JE, Gonyo P, Brandt A, Lorimer E, Unger B, Prokop JW, Heidel JR, Wang XX, Ukaegbu CI, Jennings BC, Paulo JA, Gableske S, Fierke, CA, Getz, G, Sunyaev, SR, Wade Harper, J, Cichowski, K, Kimmelman, AC, Houvras, Y, Syngal S, Williams C, Goessling W (2019) Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. Nat Genet 51(9):1308–1314
Pan Y, Liu Z, Feng Z, Hui D, Huang X, Tong D, Jin Y (2017) The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma. Tumour Biol 39(4):1010428317696230
Pylypenko O, Hammich H, Yu I-M, Houdusse A (2018) Rab GTPases and their interacting protein partners: Structural insights into Rab functional diversity. Small Gtpases 9(1–2):22–48
Rivera C (2015) Essentials of oral cancer. Int J Clin Exp Pathol 8(9):11884–11894
Shan Y, Cao W, Wang T, Jiang G, Zhang Y, Yang X (2017) ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling. Cancer Manag Res 9(1):879–889
Shikanai M, Yuzaki M, Kawauchi T (2018) Rab family small GTPases-mediated regulation of intracellular logistics in neural development. Histol Histopathol 33(8):765–771
Sieg DJ, Hauck RC, Schlaepfer DD (1999) Required role of focal adhesion kinase (FAK) for integrin—Stimulated cell migration. J Cell Sci 112(16):2677–2691
Stoopler ET, Sollecito TP (2018) Oral cancer. Dent Clin North Am 62(1):ix–x
Tai YL, Chen LC, Shen TL (2015) Emerging roles of focal adhesion kinase in cancer. Biomed Res Int 2015(1):690690
Thomson PJ (2018) Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction. J Oral Pathol Med 47(9):803–807
Tsukahara R, Umazume K, McDonald K, Kaplan HJ, Tamiya S (2017) Focal adhesion kinase family is involved in matrix contraction by transdifferentiated Müller cells. Exp Eye Res 164(1):90–94
Usman M, Ilyas A, Hashim Z, Zarina S (2020) Identification of GIMAP7 and Rabl3 as putative biomarkers for oral squamous cell carcinoma through comparative proteomic approach. Pathol Oncol Res 26(3):1817–1822
Wang S, Basson MD (2011) Protein kinase B/AKT and focal adhesion kinase: two close signaling partners in cancer. Anticancer Agents Med Chem 11(10):993–1002
Xu M, Qin S, Cao F, Ding S, Li M (2017) MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Int J Oncol 51(3):867–876
Yan C, Theodorescu D, Ye RD (2018) RAL GTPases: biology and potential as therapeutic targets in cancer. Pharmacol Rev 70(1):1–11
Zhang W, Sun J, Luo J (2016) High expression of Rab-like 3 (Rabl3) is associated with poor survival of patients with non-small cell lung cancer via repression of MAPK8/9/10-mediated autophagy. Med Sci Monit 22(1):1582–1588
Zhou J, Yi Q, Tang L (2019) The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review. J Exp Clin Cancer Res 38(1):250–260
Author information
Authors and Affiliations
Contributions
Yanrong Luo designed this manuscript. Zhiliang Xu wrote this manuscript. Zhiliang Xu, Huazhu Li and Chenyang Lin performed experiments. Binhua Zeng analyzed the data. Yulin Chen revised the language of the manuscript; all the authors approved the manuscript for submission.
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Fig. 1
Effect of PF-573,288 on RABL3 expression in CAL-27 cells. CAL-27 cells were treated with PF-573,288 (5 μM) for 24 h. The protein expression of RABL3 was measured using western blot. *p < 0.05 vs. control group. (PNG 459 kb)
Rights and permissions
About this article
Cite this article
Xu, Z., Li, H., Lin, C. et al. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway. J Bioenerg Biomembr 53, 203–211 (2021). https://doi.org/10.1007/s10863-021-09871-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-021-09871-x